Project Grant HT94252510579
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $855K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Madison, WI 53715, USA
Similar Awards
- The University of Wisconsin System was awarded a $1,555,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on population modeling to optimize equitable ovarian cancer outcomes. The grant project will take place in Madison, WI from April 15, 2025 to April 14, 2029. This federal grant program supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the...
- The University of Wisconsin System has been awarded a $516,366 federal Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program. The grant, with a performance period from September 1, 2024 to August 31, 2027, will fund research to target immunotherapy-resistant lesions and eradicate oligometastatic prostate cancer. This research initiative aims to transform healthcare for military service members and the broader...
- This $1,074,650.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research by the University of Wisconsin System to investigate the immunomodulatory effects of chemokine signaling in renal cell carcinoma. The award has a performance period from September 1, 2025 to August 31, 2029 and will fund advanced biomedical research efforts to transform healthcare for military service members, veterans, and the broader...
- The University of Wisconsin System was awarded a $1,231,201 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct advanced biomedical research on using CA9 PET/CT radiotracers to identify high-risk clear cell renal cell carcinoma patients. The project will be performed in Madison, WI with an award period from August 1, 2025 to July 31, 2028. This research supports the program's objectives of transforming healthcare for...
- The University of Wisconsin System was awarded a $1,836,030.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research to develop shark antibody radiopharmaceuticals for the treatment of prostate cancer. The research project will be conducted at the University of Wisconsin-Madison campus in Madison, Wisconsin, with a period of performance from September 1, 2025 to August 31, 2028. This...
- The University of Wisconsin System was awarded a $1,712,026 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE", will fund research at the University of Wisconsin - Madison campus between June 1, 2024 and May 31, 2028. The research aims to investigate a novel approach to addressing cognitive fatigue in military personnel. As a...
- This federal Project Grant award of $1,146,270.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Wisconsin System. The grant supports research targeting a lipid kinase regulator of nuclear AKT in breast cancer, with a performance period from July 15, 2023 to July 14, 2026. The University of Wisconsin System, through its University of Wisconsin - Madison division, will conduct this biomedical research to...
- The University of Wisconsin System was awarded a $500,000 Project Grant from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) on August 1, 2025. The grant supports the delivery of a novel immune inhibitory transgene to vascular composite allografts during normothermic preservation to decrease rejection after transplantation. This research aims to transform healthcare for military service members, veterans, and the broader public by developing innovative medical...
- This $1,251,230 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports breast cancer research by the University of Wisconsin System, with the University of Wisconsin-Madison as the lead institution. The award, effective June 15, 2025, will fund a four-year collaborative research project focused on breakthrough advancements in breast cancer clinical trials. The research aims to develop innovative medical solutions to...
- The University of Wisconsin System was awarded a $995,076 project grant by the U.S. Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support the development of new agents for the treatment of hormone receptor positive and HER2 positive breast cancer. The grant was awarded on Dec 15, 2023 and is scheduled for completion on Dec 14, 2026. As part of this project, the University of Wisconsin System has sub-awarded funding to Loyola University of...